MedDataX Logo

Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss

NCT ID: NCT01391156

Last Updated: 2012-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-31

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the efficacy of 3% Minoxidil lotion and 3% Minoxidil with 0.1% Finasteride lotion for 6 months in male pattern hair loss.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Androgenetic Alopecia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

minoxidil finasteride topical lotion male pattern hair loss androgenetic alopecia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Minoxidil

Group Type EXPERIMENTAL

3%Minoxidil lotion

Intervention Type DRUG

3% Minoxidil lotion apply two times a day

MinoxidilFinasteride

Group Type ACTIVE_COMPARATOR

3% Minoxidil with 0.1% Finasteride lotion

Intervention Type DRUG

3% Minoxidil with 0.1% Finasteride lotion apply two times a day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3%Minoxidil lotion

3% Minoxidil lotion apply two times a day

Intervention Type DRUG

3% Minoxidil with 0.1% Finasteride lotion

3% Minoxidil with 0.1% Finasteride lotion apply two times a day.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male, age 18-15 years
* androgenetic alopecia grade 3V to 5 ( Norwood-Hamilton classification)

Exclusion Criteria

* use minoxidil in 6 months
* use finasteride in 12 months
* use ketoconazole, tar, selenium shampoo, topical tretinoin, topical steroid in 2 weeks
* seborrheic dermatitis or psoriasis on scalp
* history of allergy to minoxidil, finasteride
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mae Fah Luang University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chuchai TANGLERTSAMPAN, MD

Chuchai Tanglertsampan, MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chuchai Tanglertsampan, MD

Role: PRINCIPAL_INVESTIGATOR

Mae Fah Luang University Hospital(Bangkok)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mae Fah Luang University Hospital(Bangkok)

Bangkok, Bangkok, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REH-54015

Identifier Type: -

Identifier Source: org_study_id